• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    BioNxt Utilizes Drug Delivery Strategy & Psychedelic Library

    PHARMIWEB

    Bionxt Starts GMP Production Of Cladribine Film For MS

    PHARMIWEB

    Bionxt Progresses Semaglutide In First GLP-1 ODF Platform Move

    PHARMIWEB

    Bionxt Advances Sublingual Drug Delivery With Global Patents

    PHARMIWEB

    BioNxt Secures Chaperone Tech for Oral Thin-Film Delivery

    PHARMIWEB

    BioNxt Advances MS ODF Program Toward Human Trials

    PHARMIWEB

    BioNxt Announces Success in Final Cladribine ODF In Vivo Study

    PHARMIWEB

    BioNxt Targets Global Pill-Swallowing Issue with Rapid-Dissolving

    PHARMIWEB

    BioNxt Enhances Cladribine Formulation For MS Patients

    ACCESSWIRE

    BioNxt to Acquire 100% IP and Codevelop Sublingual Formulation

    PHARMIWEB

    Bionxt Secures Eurasian Patent For Sublingual MS Therapy

    INDPHARMAPOST

    Bionxt Secures Eurasian Patent For Sublingual Cladribine Platform

    PHARMIWEB

    BioNxt Gets EPO Intention to Grant for Oral Cladribine Film

    PHARMIWEB

    Bionxt Nears Human Trials For Advanced MS Drug

    PR NEWSWIRE

    BioNxt Files Fast-Track US Patent for Sublingual Cladribine in MS

    ACCESSWIRE

    Bionxt Update On Targeted Chemotherapy Drug Delivery Platform

    PHARMAWEB

    Bionxt Advances Sublingual Cladribine For Multiple Sclerosis

    PHARMAWEB

    BioNxt Advances Semaglutide ODF Program with Prototype

    ACCESSWIRE

    BioNxt Solutions Strengthens IP Protection for Sublingual

    ACCESSWIRE

    BioNxt Solutions Closes First Tranche of Convertible Debenture

    ACCESSWIRE

    BioNxt Achieves Positive Results in Cladribine Thin-Film Program

    ACCESSWIRE

    BioNxt Gets EPO Notice of Intent to Grant New Patent

    ACCESSWIRE

    BioNxt Expands Capabilities with Munich Lab

    ACCESSWIRE

    BioNxt Expands Patent Protection for Drug Delivery Innovations

    ACCESSWIRE

    BioNxt Solutions Develops Sublingual Thin-Film for Semaglutide

    ACCESSWIRE

    Terry Lynch Joins BioNxt as Capital Markets Advisor.

    ACCESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.